Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy.
Dis Esophagus
; 21(7): 607-11, 2008.
Article
in En
| MEDLINE
| ID: mdl-18430178
ABSTRACT
Perioperative chemotherapy (CT) and chemoradiotherapy are widely used for advanced esophageal cancer. We evaluated the chemosensitivity of patients displaying recurrent esophageal cancer after esophagectomy with perioperative CT. From the database at National Cancer Center Hospital in Tokyo, we extracted recurrent esophageal cancer cases after perioperative CT and evaluated the effectiveness of the first CT against the recurrent disease according to the duration between termination of the original perioperative CT and recurrence with treatment-free intervals (TFIs)
Full text:
1
Database:
MEDLINE
Main subject:
Esophageal Neoplasms
/
Carcinoma, Squamous Cell
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Dis Esophagus
Year:
2008
Type:
Article
Affiliation country:
Japan